Alteus Global Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 13-12-2024
- Paid Up Capital ₹ 0.50 M
as on 13-12-2024
- Company Age 3 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Revenue %
(FY 2023)
- Profit 10.07%
(FY 2023)
- Ebitda 15.66%
(FY 2023)
- Net Worth -17.79%
(FY 2023)
- Total Assets 133.68%
(FY 2023)
About Alteus Global
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Nibedita Chakraborty, Debasish Mitra, and Soma Dev serve as directors at the Company.
- CIN/LLPIN
U24304WB2021PLC249646
- Company No.
249646
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
17 Nov 2021
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Company Details
- Location
Kolkata, West Bengal, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Alteus Global?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nibedita Chakraborty  | Director | 17-Nov-2021 | Current |
| Debasish Mitra | Director | 17-Nov-2021 | Current |
| Soma Dev | Director | 17-Nov-2021 | Current |
Financial Performance and Corporate Structure Insights of Alteus Global.
Alteus Global Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 10.07% increase in profit. The company's net worth observed a substantial decline by a decrease of 17.79%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Alteus Global?
In 2023, Alteus Global had a promoter holding of 99.99% and a public holding of 0.01%. The company had 2 Subsidiaries. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Alteus Biogenics Private LimitedActive 16 years 7 monthsNibedita Chakraborty, Debasish Mitra and 1 more are mutual person
Ochre Blue Retail Private LimitedActive 33 years 12 daysNibedita Chakraborty and Debasish Mitra are mutual person
- Alteus Laboratories Private LimitedActive 4 years 2 months
Nibedita Chakraborty and Debasish Mitra are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Alteus Global?
Alteus Global has a workforce of 0 employees as of Mar 29, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Alteus Global, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Alteus Global's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
